Pressure of commercialization already facing company. Squeezing of margins - manufacturing / distribution costs. Already looking at raising prices which may be OK with their beta users bc they are likely the most engaged but may not be acceptable for the average derm.
Could this thing be profitable If they just sell to most engage / highest users? TB mentioned 100 lesions per beta user per month. I don't know..very different usage from what Mela is citing
i hope vrs has some good operations / financial resources.